IL5 and asthma: Oral administration of L. reuteri ATCC 23272 also resulted in immunoregulatory effects, with elevated IL-10 levels and reduced levels of IL-5, IL-13, MCP-1, and TNF-α in OVA-induced asthma mice [52].